000			02138 a2200601 4500
005			20250517170753.0
264		0	_c20171120
008			201711s 0 0 eng d
022			_a2041-1723
024	7		_a10.1038/s41467-017-00327-8 _2doi
040			_aNLM _beng _cNLM
100	1		_aWroblewski, M
245	0	0	_aMast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B. _h[electronic resource]
260			_bNature communications _c08 2017
300			_a269 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAngiogenesis Inhibitors _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAnti-Asthmatic Agents _xpharmacology
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCromolyn Sodium _xpharmacology
650	0	4	_aEndothelial Cells _xdrug effects
650	0	4	_aExtracellular Matrix _xdrug effects
650	0	4	_aFibroblast Growth Factor 1 _xdrug effects
650	0	4	_aFibroblast Growth Factor 2 _xdrug effects
650	0	4	_aGranulocyte-Macrophage Colony-Stimulating Factor _xdrug effects
650	0	4	_aGranzymes _xmetabolism
650	0	4	_aHuman Umbilical Vein Endothelial Cells
650	0	4	_aLaminin _xmetabolism
650	0	4	_aMast Cells _xdrug effects
650	0	4	_aMice
650	0	4	_aNeoplasms _xblood supply
650	0	4	_aNeovascularization, Pathologic _xmetabolism
650	0	4	_aVascular Endothelial Growth Factor A _xdrug effects
650	0	4	_aVascular Endothelial Growth Factor Receptor-2 _xdrug effects
650	0	4	_aVitronectin _xmetabolism
700	1		_aBauer, R
700	1		_aCubas Córdova, M
700	1		_aUdonta, F
700	1		_aBen-Batalla, I
700	1		_aLegler, K
700	1		_aHauser, C
700	1		_aEgberts, J
700	1		_aJanning, M
700	1		_aVelthaus, J
700	1		_aSchulze, C
700	1		_aPantel, K
700	1		_aBokemeyer, C
700	1		_aLoges, S
773	0		_tNature communications _gvol. 8 _gno. 1 _gp. 269
856	4	0	_uhttps://doi.org/10.1038/s41467-017-00327-8 _zAvailable from publisher's website
999			_c27472008 _d27472008